quinazolines has been researched along with B16 Melanoma in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (4.76) | 18.7374 |
1990's | 3 (14.29) | 18.2507 |
2000's | 6 (28.57) | 29.6817 |
2010's | 8 (38.10) | 24.3611 |
2020's | 3 (14.29) | 2.80 |
Authors | Studies |
---|---|
Fenical, W; Hillman, PF; Kim, MJ; Lee, SE; Lim, KM; Nam, SJ; Oh, DC | 1 |
Dai, W; He, B; Meng, X; Qin, M; Wang, D; Wang, X; Yang, C; Zhang, H; Zhang, Q; Zheng, Q | 1 |
Choi, Y; Lin, H; Lin, L; Michniak-Kohn, B | 1 |
Deriabin, P; Dezhenkova, L; Gerasimenko, A; Grammatikova, N; Kaluzhny, D; Klimovich, A; Moskovkina, T; Popov, A; Shchekotikhin, A; Stonik, V; Styshova, O; Udovenko, A | 1 |
Chen, CM; Cheng, CY; Lin, KY; Lu, CY; Wu, YH | 1 |
Fu, F; Kong, X; Sun, S; Wang, H; Wang, N; Yao, J; Zhang, J | 1 |
Barry, ST; Campbell, H; Critchlow, SE; Eberlein, C; Farren, M; Frith, J; Huby, R; Kendrew, J; Michopoulos, F; Morgan, S; Patel, B; Pommier, AJ; Robertson, J; Smith, NR; Smith, PD; Wappett, M; Womack, C | 1 |
Hoeller, C; Kunstfeld, R; Loewe, R; Paulitschke, V; Pehamberger, H; Pilarski, P; Schicher, N; Swoboda, A | 1 |
Li, S; Wang, C; Wang, MW | 1 |
Bang, SC; Hwang, BY; Jung, SH; Kim, Y; Lee, JH; Lee, KC; Roh, E; Thanigaimalai, P; Yun, CY | 1 |
Cao, Z; Cheng, L; Dai, L; Deng, H; Deng, S; Feng, S; Li, W; Liu, S; Liu, Y; Ma, Y; Pan, Y; Shen, G; Shi, S; Tian, H; Wang, W; Wei, Y; Xie, H; Yang, S; Yang, Y; Zhang, N; Zhang, S; Zhao, C; Zhao, X; Zheng, R | 1 |
Langenkamp, E; Leenders, WP; Molema, G; Moorlag, HE; St Croix, B; Zwiers, PJ | 1 |
Matsunaga, T; Ogasawara, M; Saiki, I; Suzuki, H; Takahashi, S | 1 |
Ogasawara, M; Suzuki, H | 1 |
Jantová, S; Mikulásová, M; Theiszová, M | 1 |
Jantová, S; Letasiová, S; Múcková, M; Ovádeková, R | 1 |
Genady, AR | 1 |
Chen, XH; Dai, ZR; Liu, JQ; Xu, XG; Yu, AZ; Zhang, XP | 1 |
Atassi, G; Baron, M; Bissery, MC; Cros, S; Gebel-Servolles, P; Giorgi-Renault, S; Lavelle, F; Paoletti, C; Renault, J | 1 |
Osada, Y; Tanaka, NG; Tohgo, A | 1 |
Atassi, G; Dumont, P; Kabbe, HJ; Yoder, O | 1 |
21 other study(ies) available for quinazolines and B16 Melanoma
Article | Year |
---|---|
Deoxyvasicinone with Anti-Melanogenic Activity from Marine-Derived
Topics: Animals; Cell Line, Tumor; Down-Regulation; Humans; Melanins; Melanocytes; Melanoma; Melanoma, Experimental; Mice; Quinazolines; Skin; Streptomyces | 2022 |
Nano-encapsulated tryptanthrin derivative for combined anticancer therapy via inhibiting indoleamine 2,3-dioxygenase and inducing immunogenic cell death.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Female; HeLa Cells; Humans; Immunogenic Cell Death; Indoleamine-Pyrrole 2,3,-Dioxygenase; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Nanocapsules; Neoplasms; Polyesters; Quinazolines; Tumor Burden | 2019 |
Development and in-vitro evaluation of co-loaded berberine chloride and evodiamine ethosomes for treatment of melanoma.
Topics: Animals; Berberine; Drug Delivery Systems; Drug Development; Female; Humans; Liposomes; Melanoma, Experimental; Mice; Middle Aged; Plant Extracts; Quinazolines; Skin Absorption | 2020 |
Design, synthesis and biomedical evaluation of mostotrin, a new water soluble tryptanthrin derivative.
Topics: Animals; Anti-Infective Agents; Antineoplastic Agents; Cell Line, Tumor; Doxorubicin; Female; HCT116 Cells; Humans; K562 Cells; MCF-7 Cells; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Quinazolines; Structure-Activity Relationship; Water | 2020 |
Regulation of miR-21 expression in human melanoma via UV-ray-induced melanin pigmentation.
Topics: alpha-MSH; Animals; Cell Line, Tumor; Down-Regulation; ErbB Receptors; Gefitinib; Humans; Melanins; Melanoma; Melanoma, Experimental; Mice; MicroRNAs; Phosphorylation; Pigmentation; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Skin Neoplasms; Ultraviolet Rays | 2017 |
Design and Discovery of Quinazoline- and Thiourea-Containing Sorafenib Analogs as EGFR and VEGFR-2 Dual TK Inhibitors.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Drug Design; ErbB Receptors; Humans; Melanoma, Experimental; Mice, Inbred C57BL; Molecular Docking Simulation; Protein Binding; Quinazolines; Sorafenib; Thiourea; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2017 |
Leptin, BMI, and a Metabolic Gene Expression Signature Associated with Clinical Outcome to VEGF Inhibition in Colorectal Cancer.
Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Body Mass Index; Cell Line, Tumor; Colorectal Neoplasms; Humans; Kaplan-Meier Estimate; Leptin; Melanoma, Experimental; Mice; Mice, Obese; Proportional Hazards Models; Quinazolines; Retrospective Studies; Transcriptome; Treatment Outcome; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2016 |
Erlotinib and bevacizumab have synergistic activity against melanoma.
Topics: Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Immunoblotting; Immunohistochemistry; Ki-67 Antigen; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, SCID; Platelet Endothelial Cell Adhesion Molecule-1; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2009 |
Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF-kappaB signaling pathways and augmented by ubiquitin-proteasome inhibition.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Biotransformation; Blotting, Western; Caspases; Cell Death; Cell Line, Tumor; Cell Survival; Coloring Agents; Extracellular Signal-Regulated MAP Kinases; Fas Ligand Protein; Humans; Melanoma, Experimental; NF-kappa B; Oncogene Protein v-akt; Phosphatidylinositol 3-Kinases; Plant Extracts; Proteasome Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinazolines; Signal Transduction; Tetrazolium Salts; Thiazoles; Ubiquitin | 2010 |
Evaluation of 3,4-dihydroquinazoline-2(1H)-thiones as inhibitors of alpha-MSH-induced melanin production in melanoma B16 cells.
Topics: alpha-MSH; Animals; Cell Line, Tumor; Drug Evaluation, Preclinical; Magnetic Resonance Spectroscopy; Mass Spectrometry; Melanins; Melanoma, Experimental; Mice; Quinazolines; Spectroscopy, Fourier Transform Infrared | 2010 |
SKLB1002, a novel potent inhibitor of VEGF receptor 2 signaling, inhibits angiogenesis and tumor growth in vivo.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cell Line; Cell Line, Tumor; Cell Movement; Cell Proliferation; Endothelial Cells; Female; Hep G2 Cells; Humans; Melanoma, Experimental; Mice; Mice, Nude; Neoplasm Invasiveness; Neoplasms; Neovascularization, Pathologic; Neovascularization, Physiologic; Quinazolines; Signal Transduction; Thiadiazoles; Tumor Burden; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays; Zebrafish | 2011 |
Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296.
Topics: Angiogenesis Inhibitors; Animals; Carcinoma, Lewis Lung; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Immunohistochemistry; Injections, Intraperitoneal; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; MicroRNAs; Neovascularization, Pathologic; Piperidines; Quinazolines; Reverse Transcriptase Polymerase Chain Reaction; Vascular Endothelial Growth Factor Receptor-2; Xenograft Model Antitumor Assays | 2012 |
Anti-invasive and metastatic activities of evodiamine.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Cell Movement; Colonic Neoplasms; Evodia; Female; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Plant Extracts; Quinazolines | 2002 |
Inhibition by evodiamine of hepatocyte growth factor-induced invasion and migration of tumor cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma, Lewis Lung; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Colonic Neoplasms; Evodia; Hepatocyte Growth Factor; Melanoma, Experimental; Mice; Neoplasm Invasiveness; Plant Extracts; Quinazolines | 2004 |
Cytotoxic and genotoxic effects of some substituted tetrazolo[1,5-c]quinazolines.
Topics: Animals; Antineoplastic Agents; Bacteria; Cell Proliferation; Drug Screening Assays, Antitumor; Melanoma, Experimental; Mice; Microbial Sensitivity Tests; Mutagenicity Tests; Quinazolines; Structure-Activity Relationship; Tetrazoles; Tumor Cells, Cultured | 2004 |
Cytotoxic/antiproliferative effects of new [1,2,4]triazolo[4,3-c] quinazolines in tumor cell lines HeLa and B16.
Topics: Animals; Antineoplastic Agents; Cell Death; Cell Proliferation; DNA Damage; Drug Screening Assays, Antitumor; HeLa Cells; Humans; Inhibitory Concentration 50; Melanoma, Experimental; Mice; Quinazolines; Triazoles | 2006 |
Promising carboranylquinazolines for boron neutron capture therapy: synthesis, characterization, and in vitro toxicity evaluation.
Topics: Antineoplastic Agents; Boranes; Boron Neutron Capture Therapy; Cell Line, Tumor; Humans; Melanoma, Experimental; Quinazolines; Spectrum Analysis; Structure-Activity Relationship | 2009 |
[Synthesis and biological activities of 2,4-diamino-5-chloro-6-substituted quinazolines].
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Antineoplastic Agents; Leukemia L1210; Melanoma, Experimental; Mice; Microbial Sensitivity Tests; Plasmodium berghei; Quinazolines; Streptococcus pneumoniae; Tumor Cells, Cultured | 1991 |
Heterocyclic quinones. 17. A new in vivo active antineoplastic drug: 6,7-bis(1-aziridinyl)-4-[[3-(N,N-dimethylamino)propyl]amino]-5,8- quinazolinedione.
Topics: Animals; Antineoplastic Agents; Aziridines; Breast Neoplasms; Cell Division; Cell Line; Drug Screening Assays, Antitumor; Female; Humans; Leukemia L1210; Leukemia, Experimental; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Inbred DBA; Molecular Structure; Neoplasms, Experimental; Quinazolines; Sarcoma, Experimental; Structure-Activity Relationship | 1991 |
Inhibitory effects of DN-9693 on platelet-enhanced tumor cell attachment to cultured endothelium.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Animals; Blood Platelets; Calcium; Cells, Cultured; Endothelium, Vascular; Lung Neoplasms; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microscopy, Electron, Scanning; Neoplasms, Experimental; Platelet Activation; Platelet Aggregation Inhibitors; Pulmonary Artery; Quinazolines; Tumor Cells, Cultured | 1990 |
A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Colonic Neoplasms; Drug Screening Assays, Antitumor; Leukemia L1210; Leukemia P388; Melanoma, Experimental; Mice; Quinazolines | 1988 |